Bichler K H, Harzmann R, Flüchter S H, Erdmann W
Urologe A. 1982 Jan;21(1):3-8.
Improved technical conditions and progress in the standardization of staging with consistent consideration of the pathohistological grading have produced conditions which allow to adapt the transurethral resection of bladder carcinoma to the principles of tumor surgery. Therefore a prospect of cure in spite of avoiding mutilating measures can be offered to the patient with low T-category of the tumor. Precondition is the consequent application of a strict resection strategy which is adapted to the tumor and provides exact statements of the area of tumor spread and its infiltration. In a period of 5 years 207 patients with stage T3--T3 tumors were treated primarily by means of differentiated, several times repeated TUR. The corrected 3 years survival rate of altogether 146 patients was 96% for stage Ta, 70% for stage T1, 54% for T2 and 48% for T3. Proceeding from our own results the methodology, indications and limitations of the transurethral resection technique are outlined and progressive measures discussed.
技术条件的改善以及分期标准化方面的进展，同时持续考虑病理组织学分级，创造了一些条件，使得膀胱癌经尿道切除术能够遵循肿瘤外科的原则。因此，对于肿瘤T分期较低的患者，尽管避免了致残性措施，但仍有治愈的希望。前提是严格应用适应肿瘤的切除策略，并能准确说明肿瘤扩散范围及其浸润情况。在5年期间，对207例T3期肿瘤患者主要采用了分次、多次重复的经尿道切除术（TUR）进行治疗。总共146例患者的3年校正生存率，Ta期为96%，T1期为70%，T2期为54%，T3期为48%。基于我们自己的研究结果，概述了经尿道切除技术的方法、适应证和局限性，并讨论了进一步的措施。
